The relation between impaired glucose tolerance and slow coronary flow

International Journal of Cardiology

Volumn 111, Issue 1, 2006, Pages 142-146

  Binak, Emrah ^a   Gunduz, Huseyin ^b   Sahin, Muslum ^c   Kurtoglu, Nuri ^d   Dindar, Ismet ^d  

^a Turkish Heart Foundation Clinic   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c MALTEPE UNIVERSITY   (Turkey)

^d Göztepe afak Hospital   (Turkey)

Author keywords

Endothelium; Impaired glucose tolerance; Slow coronary flow

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ANGIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD FLOW VELOCITY; CORONARY CIRCULATION; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33746316847     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.09.007     Document Type: Article

References (30)

1. Tambe A.A., Demany M.A., Zimmerman H.A., and Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries. A new angiographic finding. Am Heart J 84 (1972) 66-71
2. Mosseri M., Yarom R., Gotsman M.S., and Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74 (1986) 964-972
3. Mangieri E., Macchiarelli G., Ciavolella M., et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Catheter Cardiovasc Diagn 37 (1996) 375-381
4. Kurtoglu N., Akcay A., and Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 87 (2001) 777-779
5. Beltrame J.F., Turner S.P., Leslie S.L., Solomon P., Freedman S.B., and Horowitz J.D. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol 44 (2004) 57-62
6. Cin V.G., Pekdemir H., Camsar A., et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J 44 (2003) 907-919
7. Stamler J., Vaccaro O., Neaton J.D., Wentworth D., and for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-y cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
8. Kannel W.B., and McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 241 (1979) 2035-2038
9. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., and Attali J.R. Impairment of coronary vascular reserve and Ach-induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42 (1993) 1017-1025
10. Yokoyama I., Momomura S., Ohtake T., et al. Reduced myocardial flow reserve in non-insulin dependent diabetes mellitus. J Am Coll Cardiol 30 (1997) 1472-1477
11. Pitkanen O.P., Nuutila P., Raitakari O.T., et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47 (1998) 248-254
12. Di Carli M.F., Bianco-Battles D., Landa M.E., et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100 (1999) 813-819
13. DECODE Study Group, and on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2 h diagnostic criteria. Arch Intern Med 161 (2001) 397-405
14. The DECODE Study Group, and on behalf of the European Diabetes Epidemiology Group. Is the current definition of diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular disease?. Diabetes Care 26 (2003) 688-696
15. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Coronary heart disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1 (1980) 1373-1376
16. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI farame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
17. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation: Part 1. Diagnosis and classification of diabetes mellitus (1999), Department of Noncommunicable Disease Surveillance, Geneva WHO/NCD/NCS/99.2
18. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium dependent vasodilatation in humans in vivo. Circulation 97 (1998) 1695-1701
19. Kawano H., Motoyama T., Hirashima O., et al. Hyperglycemia rapidly suppresses flow mediated endothelium dependent vasodilatation of brachial artery. J Am Coll Cardiol 34 (1999) 146-154
20. Caballero A.E., Arora S., Saouaf R., et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48 (1999) 1856-1862
21. Anastasiou E., Lekakis J.P., Alevisiaki M., et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21 (1998) 2111-2115
22. Vehkavaara S., Seppala-Lindroos A., Westerbacka J., Groop P.H., and Yki-Jarvinen H. In vivo endothelial dysfunction characterizes patients with impaired glucose tolerance. Diabetes Care 22 (1999) 2055-2060
23. Gryglewski R.J., Palmer R.M., and Moncada S. Superoxide anion is involved in the breakdown of endothelium derive vascular relaxing factor. Nature 320 (1986) 454-456
24. Mugge A., Elwell J.H., Peterson T.E., and Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 260 (1991) C219-C225
25. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., and Creager MA. Vitamin C improves endothelium dependent vasodilatation in patients with non-insulin dependent diabetes mellitus. J Clin Invest 97 (1996) 22-28
26. Timimi F.K., Ting H.H., Haley E.A., Roddy M.A., Ganz P., and Creager M.A. Vitamin C improves endothelium dependent vasodilatation in patients with insulin dependent diabetes mellitus. J Am Coll Cardiol 31 (1998) 552-557
27. Sobrevia L., and Mann G.E. Dysfunction of the endothelial nitric oxide signaling pathway in diabetes and hyperglycemia. Exp Physiol 82 (1997) 423-452
28. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787-790
29. Kawamori R. Asymptomatic hyperglycemia and early atherosclerotic changes. Diabetes Res Clin Pract 40 (1998) S35-S42
30. Yazici M., Demircan S., Aksakal E., et al. Plasma insulin, glucose and lipid levels and their relations with corrected TIMI frame count in patients with slow coronary flow. Anadolu Kardiyol Derg 3 (2003) 222-226